CREON 25000 lipase, amylase and protease enzyme preparation capsules (Switzerland)
Section 19A approved medicine
CREON 25000 lipase, amylase and protease enzyme preparation capsules (Switzerland)
Section 19A approval holder
Reach Pharmaceuticals Pty Ltd ABN 25 623 897 183
Phone
0422 429 648
Approved until
Status
Current
Medicines in short supply/unavailable
CREON 25,000 pancreatic extract 300 mg capsule bottle - ARTG 158452
Indication(s)
It is indicated as pancreatic enzyme replacement in paediatric and adult patients with pancreatic exocrine insufficiency (PEI).
Pancreatic exocrine insufficiency is often associated with, but not limited to:
- cystic fibrosis
- chronic pancreatitis
- pancreatic surgery
- gastrointestinal bypass surgery (e.g. Bilroth II gastroenterostomy)
- ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm)
Images
